Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Nextleaf Solutions Ltd.

A pioneering force in the cannabis industry, driving innovation in extraction and life science technology.

 

Bullboard - Investor Discussion Forum Nextleaf Solutions Ltd C.OILS

Alternate Symbol(s):  OILFF

Nextleaf is a federally regulated manufacturer and distributor of cannabis vapes and oils under its prohibition-era brand, Glacial Gold. The Company’s multi-patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. Nextleaf is a low-cost producer of cannabis oils, and supplies THC and CBD ingredients to partners across... see more

CSE:OILS - Post Discussion

Nextleaf Solutions Ltd > Soooo when is it our turn?
View:
Post by Rat1Race on Aug 24, 2022 10:09am

Soooo when is it our turn?

We all know of the Valens purchase from earlier this week but old news along with it was the analyst downgrade of Medipharm as well a week ago. See below. 

Looks like we're running out of compeition in the space. Hopefully that helps us stand out and brings with itr some inbound leads to the sales and marketing teams fopr more bulk orders. 

https://finance.yahoo.com/news/analysts-just-made-major-revision-101201815.html
Comment by LastoftheFranks on Aug 24, 2022 1:37pm
Not sure Medipharms and Valens would be considered competitors in the extraction space, both had exited or drastically reduced their services in that regard long ago. Remember when Adastra/Phyto Extractions was on the scene for a cup of coffee? Now they sell pre-rolls.  Not unrelated though, the demise of Valens and Medipharms extraction divisions was likely the proverbial pee in the pool ...more  
Comment by Adventurous on Aug 24, 2022 4:49pm
It begs the question: Who are now Nextleaf's competitors? It looks all open to me. Which in itself should attrack a lot of attention.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with C.OILS


Investor Presentation

View the Presentation

Investment Opportunity

  • Market Leadership with patented extraction and distillation technology offering significant efficiencies and higher purity levels over competing technologies
     
  • Debt free and four consecutive years of positive gross revenue. Reported fiscal YE 2023 gross revenue of $9.96MM with a gross profit of $2.3MM
     
  • Untapped domestic growth across various market segments, and the ability to scale production without additional capital expenditure
     
  • Backed by 19 U.S. patents and over 75 global patents provides a solid foundation for future growth and potential licensing opportunities

Nextleaf Solutions Ltd. With CEO, Emma Andrews

Primary Extraction

Distillation

Manufacturing: Softgels

The Vault

Facebook